(Newser)
–
For the first time in 13 years, the FDA has approved an anti-obesity pill. The medication, called Belviq, targets a section of the brain responsible for regulating hunger, reports Bloomberg. Sales could hit $2 billion in 2020, predicts an analyst. “Two-thirds of the people...
Read full story »
